Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate.
about
Review of photodynamic therapy in actinic keratosis and basal cell carcinomaPrediction of tumor recurrence and therapy monitoring using ultrasound-guided photoacoustic imaging.Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols.Intracellular photobleaching of 5,10,15,20-tetrakis(m-hydroxyphenyl) chlorin (Foscan) exhibits a complex dependence on oxygen level and fluence rate.Development of a novel indwelling balloon applicator for optimizing light delivery in photodynamic therapy.Long-term effectiveness of photodynamic therapy by using a hydrophilic photosensitizer ATX-S10(Na) against experimental choroidal neovascularization in rats.Prompt assessment of WST11-VTP outcome using luciferase transfected tumors enables second treatment and increase in overall therapeutic rate.Improvement of tumor response by manipulation of tumor oxygenation during photodynamic therapy.Enhancement of meta-tetrahydroxyphenylchlorin-sensitized photodynamic treatment on human tumor xenografts using a water-soluble vitamin E analogue, Trolox.Chorioretinal ischemia and angiogenic milieu following photodynamic therapy.Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liverApplication of lower fluence rate for less microvasculature damage and greater cell-killing during photodynamic therapy.Photodynamic therapy: combined modality approaches targeting the tumor microenvironment.Fluence rate as a modulator of PDT mechanisms.Local physiological changes during photodynamic therapy.Protoporphyrin IX fluorescence photobleaching and the response of rat Barrett's esophagus following 5-aminolevulinic acid photodynamic therapy.Milestones in the development of photodynamic therapy and fluorescence diagnosis.The role of oxygen monitoring during photodynamic therapy and its potential for treatment dosimetry.Light delivery over extended time periods enhances the effectiveness of photodynamic therapy.Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy.An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer.Photodynamic therapy in dermatology: a review.The effects of ultra low fluence rate single and repetitive photodynamic therapy on glioma spheroidsIrradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomasFluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.Increased cutaneous oxygen availability by topical application of hydrogen peroxide cream enhances the photodynamic reaction to topical 5-aminolevulinic acid-methyl ester.Monitoring the efficacy of antimicrobial photodynamic therapy in a murine model of cutaneous leishmaniasis using L. major expressing GFP.Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.Oxygen saturation and perfusion changes during dermatological methylaminolaevulinate photodynamic therapy.Photodynamic therapy: a new concept in medical treatment.Molecular determinants of photodynamic therapy for lung cancers.Single continuous wave laser induced photodynamic/plasmonic photothermal therapy using photosensitizer-functionalized gold nanostarsReaction of the m-THPC triplet state with the antioxidant Trolox and the anesthetic Propofol: modulation of photosensitization mechanisms relevant to photodynamic therapy?Increasing damage to tumor blood vessels during motexafin lutetium-PDT through use of low fluence rateEffect of an oxygen pressure injection (OPI) device on the oxygen saturation of patients during dermatological methyl aminolevulinate photodynamic therapy.A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer.Responses of cancer cells induced by photodynamic therapy.Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal/photodynamic therapyExplicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling.Regulation of miRNA expression by low-level laser therapy (LLLT) and photodynamic therapy (PDT)
P2860
Q24647450-E4BFF1FC-0F68-4082-822E-F8B2E5795521Q30422124-7CAFF752-8DEB-41C4-B03E-37A49E788A91Q30664446-38D6CBBC-6DA9-4F2D-89DC-8B7B255C4A45Q30810831-C6E10828-E792-4131-ABBC-49A2EBCE5B2EQ30826796-706D1DA1-B05D-440E-98F8-5237268A237BQ30833043-0DDE45B4-2809-4C58-8D9D-0990F22E44B6Q30842726-8F487887-98D9-49EA-987E-65619F719212Q30844705-B8C86748-5AE0-4F61-9011-8972DC9BBDBDQ30958989-6C5BE452-8C3F-4496-8AAB-2B222A484017Q30980461-81DD1443-FB2A-4DF7-8AE7-8F4EE39D2851Q31096932-17355DAC-EACF-4481-9A89-2F238F7A052AQ31123205-4598C696-F8E9-4ED4-A57E-8C6FD0D36F89Q33239559-C1D7CEEE-0089-4BFA-AE87-5F7E4B6B1DF6Q33239935-F64DD5AA-F787-4FD7-90ED-397B06A390B5Q33247400-16BA61CA-7128-4605-9D4A-F4E060C37ADCQ33252347-A4043496-44EB-4506-BF2D-FDC3A53C48F6Q33307700-40A9230D-6C1F-4DBB-B852-EF1300456EF6Q33307701-BBB250C4-3B93-41C0-A2DF-AB502960739EQ33331297-ECA83B2F-A959-4F34-8CAA-BD1763B797D5Q33344854-16CFCF8D-FB20-4A67-B5A1-29ECDD5E780BQ33420038-8F5A4F1B-8E8E-47B1-B34E-DCCFE132A8E2Q33490169-6E7C631B-909A-4840-8AA7-8F6F40E59DB2Q33500227-A6E4BF15-A0CA-447D-8043-A523C00A6E42Q33608243-03D4A362-3579-44F4-8667-6C1998F71109Q33709517-254AC391-1116-4B87-8B67-2F01A741771EQ33811000-97F9A1DB-D1F2-4BF7-A3F6-B39B140A1A03Q33876004-6C978358-6B5F-44F4-888B-026F173EC417Q33960755-36BCC2F4-37BE-4BC9-A5DB-183E1FABC186Q33975388-731846BB-6865-43F9-A01B-2FE6119B19F8Q34056199-990BF651-AD8F-465C-AF5B-570C2E8241EBQ34068136-CDE89205-FD8A-4089-9258-D5D98E61C84FQ34069167-B42FB38F-2CEE-4A10-8B8F-2FEA4385DF3AQ34151225-5FCF292A-026C-445B-8F92-9DFA3DEB82B7Q34373293-46EB56F5-168E-4F4A-AC33-EC4D38D7070FQ34394896-C750A06D-7919-4729-9662-7E069DE33FE4Q34579768-488D8CD2-3F1D-4EF2-A3AE-D7A991609536Q34624384-C97B4AE6-92C5-411A-91EF-08B8AD999737Q34747955-5A93677D-3A15-4003-AF5B-08858146BE45Q34768606-1728447B-9CC4-409B-9EDE-BF9C6F7CB105Q34786279-E646264D-0CAB-4D24-BB32-ACDA4B848C67
P2860
Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Reduction of tumour oxygenatio ...... vivo: effects of fluence rate.
@ast
Reduction of tumour oxygenatio ...... vivo: effects of fluence rate.
@en
type
label
Reduction of tumour oxygenatio ...... vivo: effects of fluence rate.
@ast
Reduction of tumour oxygenatio ...... vivo: effects of fluence rate.
@en
prefLabel
Reduction of tumour oxygenatio ...... vivo: effects of fluence rate.
@ast
Reduction of tumour oxygenatio ...... vivo: effects of fluence rate.
@en
P2093
P2860
P356
P1476
Reduction of tumour oxygenatio ...... vivo: effects of fluence rate.
@en
P2093
B W Henderson
J A Hampton
T M Sitnik
P2860
P2888
P304
P356
10.1038/BJC.1998.231
P407
P577
1998-05-01T00:00:00Z